Indoco Remedies reported its Q3 financial results, showing steady growth in revenue and operating profitability on a year-on-year basis, while the company continued to post a net loss during the quarter.
For Q3, Indoco Remedies’ revenue increased 8.5% year-on-year to ₹445.4 crore, compared with ₹410.6 crore in the corresponding quarter last year. The rise in topline indicates stable business activity across segments, even as profitability at the net level remained under pressure.
At the operating level, EBITDA improved sharply to ₹31.5 crore in Q3, compared with ₹12 crore in the same period last year. This translated into a significant expansion in EBITDA margin to 7.1% from 2.9% on a year-on-year basis, reflecting better operating leverage and cost management during the quarter.
However, at the bottom line, Indoco Remedies reported a net loss of ₹29.8 crore in Q3, compared with a loss of ₹26.4 crore in the year-ago quarter.
